Lyra Therapeutics Inc LYRA

‎$‎0.49490.09(23.42%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Lyra Therapeutics Inc
Today

Create an eToro account to buy LYRA stock on a secure, user-friendly, multi-asset trading platform.

Lyra Therapeutics Inc LYRA

Buy LYRA

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Exela Technologies Pref

Larsen & Toubro Limited

‎$‎37.15

+0.41%

1585.HK

Yadea Group Holdings Ltd

‎$‎12.68

+5.67%

IFL.ASX

Insignia Financial Ltd

‎A$‎4.74

MHID.L

Mahindra & Mahindra Limited

Lyra Therapeutics Inc News

Lyra Therapeutics Withdraws Nasdaq Appeal, Faces Imminent Delisting

MAX

*Past performance is not an indication of future results

Jump to:

About LYRA >
How to Buy? >
News >
Top Guides >

The Lyra Therapeutics Inc share price is stable this week.

The Lyra Therapeutics Inc share price today is ‎$‎0.4949, reflecting a ‎23.42‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of LYRA is ‎$‎711700 with an average volume in the last three months of 105947.3. The stock has a P/E ratio of -0.02 and a dividend yield of 0%. With the stock’s beta sitting at -0.5

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

LYRA Key Metrics

Market Cap

‎$‎711700

Day’s Range

‎$‎0.4807 - ‎$‎1.28

52W Range

‎$‎0.4807 - ‎$‎35.64

Average Volume (3M)

105947.3

Price-Earnings Ratio

-0.02

Revenue

‎$‎600000

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎0.401

EPS

‎$‎-23.78

Beta

-0.5

How can I buy Lyra Therapeutics Inc stocks?

To purchase Lyra Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Lyra Therapeutics Inc (LYRA) page and place an order to buy Lyra Therapeutics Inc.

Buy LYRA

Looking for more information? Check out our guide on Academy.

What Is Lyra Therapeutics Inc?

Lyra Therapeutics, Inc. is a clinical-stage biotechnology therapeutics company committed to developing medicine to treat severe ear, nose and throat (ENT) diseases. The company operates primarily across North America and worldwide in clinical trials and research efforts.

The company functions within the biotechnology sector, in ENT disease therapeutics. Lyra Therapeutics’ well-known product, LYR-210, is designed to provide up to six months of continuous drug therapy for chronic rhinosinusitis (CRS) sufferers.

Diversify your virtual portfolio by following LYRA shares on eToro.

CEO

Maria Palasis, PhD

Employees

Founded

2005

Watertown, Massachusetts, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Lyra Therapeutics Inc
Today

Create an eToro account to buy LYRA stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Lyra Therapeutics Inc stock?

The current price of LYRA is ‎$‎0.4949.

What are analysts’ forecasts for Lyra Therapeutics Inc?

Analysts offer forecasts for Lyra Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Lyra Therapeutics Inc?

The market capitalisation of Lyra Therapeutics Inc is ‎$‎711700

Daily Movers

Explore the biggest stocks movers on the market.